Granted Patent
B2
US 7,229,824 · App. 10/621,741 · Granted Jun 12, 2007
Ribonucleases and methods of making them recombinantly
Assignee:
Alfacell Corporation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Methods for recombinantly producing new RNases, as well as previously-known RNases, are disclosed. The new RNases are active against human carcinoma cells.
Claims (3)
1. A vector containing the DNA of SEQ ID NO: 2 encoding the ribonuclease of SEQ ID NO: 1.
2. A pET11d plasmid vector containing the DNA of SEQ ID NO: 2 encoding the ribonuclease of SEQ ID NO: 1.
3. A pET22b plasmid vector containing the DNA of SEQ ID NO: 2 encoding the ribonuclease of SEQ ID NO: 1.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 10, 2020
From: TAMIR BIOTECHNOLOGY, INC.
To: ORGENESIS INC.
Reel/Frame 052892/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 1, 2004
From: SAXENA, SHAILENDRA K.
To: ALFACELL CORPORATION
Reel/Frame 014385/0201 →
Continuity (1)